Spontaneous establishment and characterization of mouse keratinocyte cell lines in serum-free medium.
Mouse keratinocytes cultures readily develop into established cell lines without undergoing a "crisis" in a newly-developed serum-free medium, LEP/MK2. LEP/MK2 consists of calcium-free MEM with non-essential amino acids supplemented with 8 factors. Two lines, MK1 and MKDC4, have been isolated and have now doubled more than 400 and 200 times respectively. In MK1 cells, Giemsa banding has revealed significant karyotypic changes as early as the 4th passage, leading to a near-tetraploid karyotype with random loss and gain of individual chromosomes. Minute chromosomes, but no stable markers have been observed. After these initial changes, examination of cultures at several passage levels has shown that the karyotype has remained essentially stable. The MKDC4 line, also sub-tetraploid at the 7th passage, had 4 marker chromosomes by the 47th passage. The rapid increase in chromosome number may have contributed to the "immortalization" of these lines. The response of these established keratinocyte lines to growth factors and serum-derived inhibitors changed with increasing passage level. Most notable of these changes were a reduction in the requirement for bovine pituitary extract (an absolute requirement for growth of secondary MK1 cells) and a decreased sensitivity to serum and serum-derived inhibitors, e.g., transforming growth factor-beta. The established lines, like primary and secondary keratinocytes, remain responsive to calcium-induced terminal differentiation and are non-tumorigenic in athymic, nude mice. This serum-free system is suitable for transformation studies with oncogenes and chemical carcinogens.
Kaighn
M E
ME
Laboratory of Experimental Pathology, National Cancer Institute, Bethesda, MD 20892.
Camalier
R F
RF
Bertolero
F
F
Saffiotti
U
U
D000818:Animals; D002118:Calcium / Q000494:pharmacology; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D003470:Culture Media; D004305:Dose-Response Relationship, Drug; D000078404:Epidermal Cells; D006133:Growth Substances / Q000008:administration & dosage; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D007621:Karyotyping; D007633:Keratins; D051379:Mice; D008819:Mice, Nude; D009374:Neoplasms, Experimental / Q000473:pathology; D010455:Peptides / Q000494:pharmacology; D010902:Pituitary Gland / Q000502:physiology; D014020:Tissue Extracts / Q000494:pharmacology; D015291:Transforming Growth Factors
D003470:Culture Media; D006133:Growth Substances; D010455:Peptides; D014020:Tissue Extracts; D007334:Insulin-Like Growth Factor I; D007633:Keratins; D015291:Transforming Growth Factors; D002118:Calcium